Novel Inhibitors of T315I Mutant BCR-ABL1 Tyrosine Kinase for Chronic Myeloid Leukemia Disease Through Fragment-Based Drug Design

Satya Anindita, Atika Marnolia, Hersal Hermana Putra, Muhammad Chandra Haikal, Usman Sumo Friend Tambunan. Novel Inhibitors of T315I Mutant BCR-ABL1 Tyrosine Kinase for Chronic Myeloid Leukemia Disease Through Fragment-Based Drug Design. In Fa Zhang, Zhipeng Cai, Pavel Skums, Shihua Zhang, editors, Bioinformatics Research and Applications - 14th International Symposium, ISBRA 2018, Beijing, China, June 8-11, 2018, Proceedings. Volume 10847 of Lecture Notes in Computer Science, pages 185-190, Springer, 2018. [doi]

@inproceedings{AninditaMPHT18,
  title = {Novel Inhibitors of T315I Mutant BCR-ABL1 Tyrosine Kinase for Chronic Myeloid Leukemia Disease Through Fragment-Based Drug Design},
  author = {Satya Anindita and Atika Marnolia and Hersal Hermana Putra and Muhammad Chandra Haikal and Usman Sumo Friend Tambunan},
  year = {2018},
  doi = {10.1007/978-3-319-94968-0_17},
  url = {https://doi.org/10.1007/978-3-319-94968-0_17},
  researchr = {https://researchr.org/publication/AninditaMPHT18},
  cites = {0},
  citedby = {0},
  pages = {185-190},
  booktitle = {Bioinformatics Research and Applications - 14th International Symposium, ISBRA 2018, Beijing, China, June 8-11, 2018, Proceedings},
  editor = {Fa Zhang and Zhipeng Cai and Pavel Skums and Shihua Zhang},
  volume = {10847},
  series = {Lecture Notes in Computer Science},
  publisher = {Springer},
  isbn = {978-3-319-94968-0},
}